Jack Nathan Medical Corp. (JNHMF)

Jack Nathan Medical Corp. (JNHMF) — VMCI valuation read

Composite valuation read on JNHMF: VMCI 50/100 against a Healthcare sector median of 50. The 0-point above-median print is the headline number for Jack Nathan Medical Corp., and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for JNHMF: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on JNHMF: JNHMF trades at 21.0x earnings, 17% above the Healthcare median of 18.0x; ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp; net debt to EBITDA of 3.2x is the binding constraint on the bear case. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.

JNHMF rose 2.0% over the trailing 7 days, with a -14.4% read on a 30-day basis.